50+ Hematological Definitions Every Student Needs

Hematological definitions are the specialized terms used to describe blood cells, blood-forming organs, blood diseases, and the laboratory values that guide diagnosis and treatment. Whether you’re a medical student cramming for boards, a nursing professional interpreting lab results, or a patient trying to decode a report, knowing these terms is the difference between confusion and clarity.

This reference covers over 50 core hematological definitions organized by category — from basic blood cell terminology to disease-specific vocabulary — along with normal lab values, clinical thresholds, and the context you actually need to make these terms stick.

Blood Cell Definitions: The Basics

Blood is a connective tissue composed of plasma (the liquid portion, roughly 55% of blood volume) and formed elements (cells and cell fragments, about 45%). Here are the foundational terms:

• Erythrocytes (Red Blood Cells/RBCs): Biconcave, anucleated cells that transport oxygen via hemoglobin. Normal count: 4.5–5.5 million cells/µL in men, 4.0–5.0 million/µL in women.
• Leukocytes (White Blood Cells/WBCs): Nucleated immune cells. Normal range: 4,500–11,000 cells/µL.
• Thrombocytes (Platelets): Cell fragments from megakaryocytes that initiate clot formation. Normal range: 150,000–400,000/µL.
• Reticulocytes: Immature RBCs released from bone marrow. A reticulocyte count of 0.5–2.5% indicates normal marrow output.
• Hematocrit (Hct): The percentage of blood volume occupied by red blood cells. Normal: 38–50% in men, 36–44% in women.
• Hemoglobin (Hgb): The oxygen-carrying protein inside RBCs. Normal: 13.5–17.5 g/dL in men, 12.0–16.0 g/dL in women.

Normal Hematological Lab Values: Quick Reference Table

This table covers the values you’ll encounter most frequently on a Complete Blood Count (CBC), the single most ordered blood test in medicine:

Red Blood Cell Terminology

Red cell definitions often describe abnormalities in size, shape, or hemoglobin content. These terms appear constantly in pathology reports:

• Erythropoiesis: The production of red blood cells, primarily in bone marrow, driven by the hormone erythropoietin (EPO) from the kidneys.
• Anisocytosis: Variation in RBC size. Detected by an elevated RDW (Red Cell Distribution Width).
• Poikilocytosis: Variation in RBC shape — includes target cells, sickle cells, tear drop cells, and more.
• Microcytosis: Abnormally small RBCs (MCV below 80 fL). Think iron deficiency, thalassemia.
• Macrocytosis: Abnormally large RBCs (MCV above 100 fL). Think B12/folate deficiency, liver disease, alcohol use.
• Polychromasia: The presence of bluish-staining RBCs on a peripheral smear, indicating reticulocytes and active marrow response.
• Spherocytosis: Spherical RBCs that lack the normal biconcave shape, seen in hereditary spherocytosis and autoimmune hemolytic anemia.

White Blood Cell Definitions

The WBC differential breaks leukocytes into five main types. Shifts in these populations tell a specific clinical story:

• Neutrophils (40–70%): First responders to bacterial infections. Neutropenia (below 1,500/µL) significantly increases infection risk; below 500/µL is severe.
• Lymphocytes (20–40%): Key players in viral defense and adaptive immunity. Includes T-cells, B-cells, and NK cells.
• Monocytes (2–8%): Differentiate into macrophages in tissues. Elevated in chronic infections like tuberculosis.
• Eosinophils (1–4%): Elevated in parasitic infections and allergic conditions.
• Basophils (0.5–1%): Rarest WBC type; involved in allergic and inflammatory responses via histamine release.
• Leukocytosis: WBC count above 11,000/µL — most commonly caused by infection, inflammation, or stress.
• Leukopenia: WBC count below 4,500/µL — suggests marrow suppression, viral infection, or autoimmune destruction.
• Left shift: An increase in immature neutrophils (bands) on the differential, indicating the marrow is ramping up production — a classic sign of acute bacterial infection.

Coagulation and Hemostasis Definitions

Hemostasis is the process that stops bleeding. It involves three overlapping phases: vascular spasm, platelet plug formation, and the coagulation cascade. Here are the terms you need:

• Thrombocytopenia: Platelet count below 150,000/µL. Causes include ITP, TTP, HIT, and bone marrow disorders.
• Thrombocytosis: Platelet count above 400,000/µL. Can be reactive (infection, iron deficiency) or clonal (essential thrombocythemia).
• PT (Prothrombin Time): Measures the extrinsic pathway. Normal: 11–13.5 seconds. Monitored in warfarin therapy.
• INR (International Normalized Ratio): Standardized PT ratio. Therapeutic range on warfarin: 2.0–3.0 for most indications.
• aPTT (Activated Partial Thromboplastin Time): Measures the intrinsic pathway. Normal: 25–35 seconds. Monitored in heparin therapy.
• D-dimer: A fibrin degradation product. Elevated levels suggest active clot breakdown — used to help rule out DVT and pulmonary embolism.
• DIC (Disseminated Intravascular Coagulation): A life-threatening condition with simultaneous widespread clotting and bleeding. Labs show elevated PT, aPTT, D-dimer, and low fibrinogen.

Hematological Disease Definitions

Anemias

Anemia is defined as hemoglobin below 13.5 g/dL in men or below 12.0 g/dL in women. It’s classified by MCV:

• Microcytic anemia (MCV <80): Iron deficiency (most common worldwide), thalassemia, anemia of chronic disease, sideroblastic anemia.
• Normocytic anemia (MCV 80–100): Acute blood loss, anemia of chronic disease, aplastic anemia, hemolytic anemias.
• Macrocytic anemia (MCV >100): B12 deficiency, folate deficiency, myelodysplastic syndrome, liver disease.

Hematologic Malignancies

• Leukemia: Cancer of blood-forming cells, classified as acute or chronic and lymphoid or myeloid (ALL, AML, CLL, CML).
• Lymphoma: Cancer originating in the lymphatic system — divided into Hodgkin lymphoma and non-Hodgkin lymphoma.
• Multiple myeloma: Malignancy of plasma cells in bone marrow, characterized by the CRAB criteria — Calcium elevation, Renal insufficiency, Anemia, and Bone lesions.
• Myelodysplastic syndrome (MDS): A group of clonal disorders with ineffective hematopoiesis and risk of transformation to AML.

Bleeding and Clotting Disorders

• Hemophilia A: Factor VIII deficiency (X-linked). Affects ~1 in 5,000 male births.
• Hemophilia B: Factor IX deficiency (Christmas disease).
• Von Willebrand Disease: The most common inherited bleeding disorder, affecting up to 1% of the population. Caused by deficient or dysfunctional von Willebrand factor.
• Factor V Leiden: The most common inherited thrombophilia, present in ~5% of Caucasians. Increases risk of venous thromboembolism.

Diagnostic Terminology

Beyond the CBC, hematologists rely on several specialized tests:

• Peripheral blood smear: Manual microscopic examination of blood cell morphology — often the single most revealing test in hematology.
• Bone marrow biopsy: Extraction and examination of marrow tissue to evaluate cellularity, fibrosis, and abnormal cell populations.
• Flow cytometry: Identifies cell surface markers (CD antigens) to classify leukemias and lymphomas.
• Coombs test (Direct Antiglobulin Test): Detects antibodies bound to red blood cells — essential for diagnosing autoimmune hemolytic anemia.
• Hemoglobin electrophoresis: Separates hemoglobin variants to diagnose sickle cell disease and thalassemias.

Frequently Asked Questions

What’s the difference between hematology and oncology?

Hematology covers all blood disorders — benign and malignant. Oncology focuses on cancer. Because blood cancers (leukemia, lymphoma, myeloma) sit at the intersection, many specialists train in both fields as hematologist-oncologists. However, a hematologist also manages non-cancerous conditions like anemia, clotting disorders, and sickle cell disease.

Which hematological definitions appear most on medical board exams?

High-yield terms include MCV-based anemia classification, the coagulation cascade (PT vs. aPTT and what each measures), DIC criteria, the WBC differential and what shifts mean, and the CRAB criteria for multiple myeloma. Master these and you’ll cover a large percentage of hematology board questions.

What does “left shift” mean on a CBC?

A left shift means there’s an increase in band cells (immature neutrophils) in the peripheral blood, typically above 6%. It signals that the bone marrow is releasing cells early to fight an acute infection — most often bacterial. The term comes from old lab equipment where immature cells appeared on the left side of the printout.

When should I worry about abnormal blood counts?

Mildly abnormal values are common and often benign. Red flags that warrant prompt evaluation include: hemoglobin below 7 g/dL, WBC above 30,000/µL or below 1,000/µL, platelets below 50,000/µL, or any combination of two or three low cell lines (called bicytopenia or pancytopenia), which can indicate bone marrow failure.

What is a hematological malignancy vs. a solid tumor?

Hematological malignancies arise from blood-forming cells — they circulate through the blood and marrow rather than forming a discrete mass in one organ. Solid tumors (breast, lung, colon cancer) grow as localized masses that may later metastasize. This distinction matters because staging systems, treatment approaches, and prognosis differ significantly between the two categories.

When to See a Hematologist

Your primary care doctor may refer you to a hematologist if you have:

• Persistent anemia that doesn’t respond to iron or vitamin supplementation
• Unexplained bruising or bleeding (nosebleeds lasting over 20 minutes, heavy menstrual periods, bleeding gums)
• Recurrent blood clots, especially before age 50 or without obvious risk factors
• Abnormal CBC results with significantly elevated or depressed cell counts
• A family history of blood cancers, sickle cell disease, or clotting disorders

Don’t wait for a referral if you’re experiencing severe fatigue combined with easy bruising, unintentional weight loss, or night sweats — these symptoms together can signal hematologic malignancy and deserve urgent evaluation.